Bio-Rad Laboratories, Inc. (BIO)

Bio-Rad Laboratories Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Bio-Rad Laboratories stock have an average target of 415.25, with a low estimate of 345 and a high estimate of 481. The average target predicts an increase of 70.88% from the current stock price of 243.00.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$345	$415.25	$450	$481
Change	+41.98%	+70.88%	+85.19%	+97.94%

* Price targets were last updated on Feb 12, 2025.

Analyst Ratings

The average analyst rating for Bio-Rad Laboratories stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brandon Couillard Wells Fargo	Wells Fargo	Hold Maintains $360 → $345	Hold	Maintains	$360 → $345	+41.98%	Feb 12, 2025
Conor McNamara RBC Capital	RBC Capital	Buy Reiterates $481	Buy	Reiterates	$481	+97.94%	Jan 14, 2025
Conor McNamara RBC Capital	RBC Capital	Buy Maintains $369 → $481	Buy	Maintains	$369 → $481	+97.94%	Dec 9, 2024
Patrick Donnelly Citigroup	Citigroup	Strong Buy Maintains $400 → $450	Strong Buy	Maintains	$400 → $450	+85.19%	Oct 31, 2024
Conor McNamara RBC Capital	RBC Capital	Buy Maintains $446 → $469	Buy	Maintains	$446 → $469	+93.00%	Oct 31, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

2.60B

Increased by 1.11%

from 2.57B

Revenue Next Year

2.71B

Increased by 4.55%

from 2.60B

EPS This Year

9.80

from -65.36

EPS Next Year

11.45

Increased by 16.79%

from 9.80

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	2.55B	2.92B	2.80B	2.67B	2.57B	2.60B	2.71B	2.83B
Revenue Growth	10.12%	14.81%	-4.12%	-4.68%	-3.92%	1.11%	4.55%	4.24%
EPS	126.47	140.83	-121.79	-21.82	-65.36	9.80	11.45	12.19
EPS Growth	117.04%	11.35%	-	-	-	-	16.79%	6.51%
Forward PE	-	-	-	-	-	24.79	21.23	19.93
No. Analysts	-	-	-	-	-	9	9	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028
High	2.8B	2.9B	3.0B
Avg	2.6B	2.7B	2.8B
Low	2.5B	2.6B	2.6B

Revenue Growth

Revenue Growth	2025	2026	2027	2028
High	7.7%	10.4%	11.3%
Avg	1.1%	4.5%	4.2%
Low	-3.4%	-1.5%	-2.5%

EPS Forecast

EPS	2025	2026	2027	2028
High	10.76	13.26	14.18
Avg	9.80	11.45	12.19
Low	8.43	9.21	10.17

EPS Growth

EPS Growth	2025	2026	2027	2028
High	-	35.3%	23.8%
Avg	-	16.8%	6.5%
Low	-	-6.0%	-11.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.